KR — ZDNet Korea
Arizona Veterans Research and Education Foundation and Young Blood Institute Announce CRADA for Alzheimer's Pilot Study, Supporting Phoenix VA Health Care System
Policy2 min read
Ambarri Healthcare and the Young Blood Institute (YBI) announced a research deal with the Phoenix VA Health Care System and the Arizona Veterans Research and Education Foundation. They will test a blood-cleaning treatment in military veterans who have early Alzheimer's disease.
What happened
On November 19, 2026, four groups announced a cooperative research and development agreement (CRADA). The groups are AmβARI Healthcare, the Phoenix VA Health Care System, the Arizona Veterans Research and Education Foundation, and the Young Blood Institute. Together they will run a small pilot study. It tests an improved form of therapeutic plasma exchange (TPE). TPE is a treatment that removes part of the blood's plasma, the liquid part of blood, and replaces it. The study will look at veterans with mild cognitive impairment (MCI) or early-stage Alzheimer's disease.
Key numbers and facts
- The study is called the AMBAR VA study (VA protocol 1859907).
- Up to 56 veterans will join. It is a randomized controlled trial, meaning people are assigned to groups by chance and compared.
- The main measure is the change in amyloid in the brain. Amyloid is a sticky protein linked to Alzheimer's. It is measured with brain PET-CT scans that use a tracer called NAV-4694.
- In earlier AMBAR trials, 61% of patients with early to moderate Alzheimer's had slower or stopped disease progression. Memory improved in 11% to 15% of patients.
- The original AMBAR trial included 498 patients. The Ace Alzheimer Center Barcelona has done over 2,100 standard TPE treatments.
Background
Alzheimer's disease slowly destroys memory and thinking skills. Researchers are testing many ways to slow it. TPE is one of them. The idea is that removing harmful proteins from the blood may also reduce them in the brain. The Young Blood Institute is a nonprofit clinical research group in the United States. Ambarri Healthcare is its exclusive partner and pays for the research. The Phoenix VA Health Care System serves about 130,000 veterans in Arizona.
Why it matters
Alzheimer's is a serious disease, and few treatments can slow it down. If this pilot study shows good results, doctors could offer a new option to veterans. The study also tests whether the amyloid idea of Alzheimer's is correct. The study runs under federal rules and is overseen by the VA's Institutional Review Board (IRB), a group that checks that research is safe and ethical.
What to watch
- Whether the 56 veterans are enrolled as planned.
- Whether the brain scans show less amyloid in the treatment group.
- Whether the study shows how TPE removes amyloid from the brain.
- Whether the results are strong enough for larger studies.
Glossary
- TPE
- Therapeutic plasma exchange: a treatment that removes and replaces part of the blood's plasma (the liquid part of blood).
- CRADA
- Cooperative Research and Development Agreement: a formal deal that lets government and outside groups work on research together.
- Young Blood Institute (YBI)
- A nonprofit clinical research group that supports biomedical research.
- Amyloid
- A sticky protein that builds up in the brain and is linked to Alzheimer's disease.